Australia's Cambium Bio hits 7-week high on premium placement
20/01/2026 24:58
** Cambium Bio CMB.AX jumps 13% to A$0.52, highest since November 27, 2025 ** Regenerative medicine co secures A$2.4 million strategic investment from major shareholder Zheng Yang Biomedical Technology Co ** Investment via placement of 4.4 mln new shares at A$0.55/share, representing 19.6% premium to last close ** YTD, CMB up 10.6% (Reporting by Shruti Agarwal in Bengaluru) ((Shruti.Agarwal@thomsonreuters.com))
Recent news on Cambium Bio
See all newsAustralia's Cambium Bio hits near three-month high on share placement at premium
Brief: Cambium Bio Appoints Olga Smejkalova As Company Secretary
Australia's Cambium Bio gains after premium share placement
Brief: Cambium Bio Raises A$1 MLN At A$0.48 Per Share
Brief: Cambium Bio Receives A$2.4 Million Investment From Zheng Yang Biomedical Technology